Zobrazeno 1 - 10
of 394
pro vyhledávání: '"Shuying S. Li"'
Autor:
Daniel J. Schuster, Shelly Karuna, Caroline Brackett, Martina Wesley, Shuying S. Li, Nathan Eisel, DeAnna Tenney, Sir’Tauria Hilliard, Nicole L. Yates, Jack R. Heptinstall, LaTonya D. Williams, Xiaoying Shen, Robert Rolfe, Robinson Cabello, Lu Zhang, Sheetal Sawant, Jiani Hu, April Kaur Randhawa, Ollivier Hyrien, John A. Hural, Lawrence Corey, Ian Frank, Georgia D. Tomaras, Kelly E. Seaton, HVTN 405/HPTN 1901 Study Team
Publikováno v:
JCI Insight, Vol 7, Iss 21 (2022)
People living with HIV-1 (PLWH) exhibit more rapid antibody decline following routine immunization and elevated baseline chronic inflammation than people without HIV-1 (PWOH), indicating potential for diminished humoral immunity during SARS-CoV-2 inf
Externí odkaz:
https://doaj.org/article/297bf81be35848f98a4923e358e65b11
Autor:
Kelly E. Seaton, Aaron Deal, Xue Han, Shuying S. Li, Ashley Clayton, Jack Heptinstall, Ann Duerr, Mary A. Allen, Xiaoying Shen, Sheetal Sawant, Nicole L. Yates, Paul Spearman, Gavin Churchyard, Paul A. Goepfert, Janine Maenza, Glenda Gray, Giuseppe Pantaleo, Laura Polakowski, Harriet L. Robinson, Shannon Grant, April K. Randhawa, Ying Huang, Cecilia Morgan, Nicole Grunenberg, Shelly Karuna, Peter B. Gilbert, M. Juliana McElrath, Yunda Huang, Georgia D. Tomaras, NIAID HIV Vaccine Trials Network (HVTN) 076, 088, 086, 096, 097, 205 Study Teams
Publikováno v:
npj Vaccines, Vol 6, Iss 1, Pp 1-11 (2021)
Abstract We studied mucosal immune responses in six HIV-1 vaccine trials investigating different envelope (Env)-containing immunogens. Regimens were classified into four categories: DNA/vector, DNA/vector plus protein, protein alone, and vector alone
Externí odkaz:
https://doaj.org/article/2f212191b8044471a09de9b169fd03d0
Autor:
Johanna W. Lampe, Mark Kestin, Lin Li, Shuying S. Li, Irena B. King, Yvonne Schwarz, Karen W. Makar, Chu Chen, Sabrina Peterson, Sandi L. Navarro
Perspective on this Article from Cruciferous Vegetable Feeding Alters UGT1A1 Activity: Diet- and Genotype-Dependent Changes in Serum Bilirubin in a Controlled Feeding Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62bb2058a7195e83a4e4d7062a942c62
https://doi.org/10.1158/1940-6207.22523179.v1
https://doi.org/10.1158/1940-6207.22523179.v1
Autor:
Marnie L Elizaga, Shuying S Li, Nidhi K Kochar, Gregory J Wilson, Mary A Allen, Hong Van N Tieu, Ian Frank, Magdalena E Sobieszczyk, Kristen W Cohen, Brittany Sanchez, Theresa E Latham, David K Clarke, Michael A Egan, John H Eldridge, Drew Hannaman, Rong Xu, Ayuko Ota-Setlik, M Juliana McElrath, Christine Mhorag Hay, NIAID HIV Vaccine Trials Network (HVTN) 087 Study Team
Publikováno v:
PLoS ONE, Vol 13, Iss 9, p e0202753 (2018)
BACKGROUND:The addition of plasmid cytokine adjuvants, electroporation, and live attenuated viral vectors may further optimize immune responses to DNA vaccines in heterologous prime-boost combinations. The objective of this study was to test the safe
Externí odkaz:
https://doaj.org/article/799ab45103694bff91a425fb6ec10484
Autor:
Daniel J. Schuster, Shelly T. Karuna, Caroline Brackett, Martina Wesley, Shuying S. Li, Nathan Eisel, DeAnna Tenney, Sir'Tauria Hilliard, Nicole L. Yates, Jack Heptinstall, LaTonya Williams, Xiaoying Shen, Robert Rolfe, Robinson Cabello, Lu Zhang, Sheetal Sawant, Jiani Hu, April Randhawa, Ollivier Hyrien, John Hural, Lawrence Corey, Ian Frank, Georgia D. Tomaras, Kelly E. Seaton
Publikováno v:
SSRN Electronic Journal.
Autor:
Shuying S. Li, Andrew Hickey, Shida Shangguan, Philip K. Ehrenberg, Aviva Geretz, Lauryn Butler, Gautam Kundu, Richard Apps, Matthew Creegan, Robert J. Clifford, Suteeraporn Pinyakorn, Leigh Anne Eller, Pikunchai Luechai, Peter B. Gilbert, Timothy H. Holtz, Anupong Chitwarakorn, Carlo Sacdalan, Eugène Kroon, Nittaya Phanuphak, Mark de Souza, Jintanat Ananworanich, Robert J. O'Connell, Merlin L. Robb, Nelson L. Michael, Sandhya Vasan, Rasmi Thomas
Publikováno v:
Cell Host Microbe
Cell host & microbe, 30(8), 1173-1185.E8. Cell Press
Cell host & microbe, 30(8), 1173-1185.E8. Cell Press
Human leukocyte antigen (HLA) alleles have been linked to HIV disease progression and attributed to differences in cytotoxic T lymphocyte (CTL) epitope representation. These findings are largely based on treatment-naive individuals of European and Af
Autor:
M. Juliana McElrath, Jack Heptinstall, Xiaoying Shen, Cecilia Morgan, Shuying S. Li, Harriet L. Robinson, Giuseppe Pantaleo, Shelly Karuna, Nicole L. Yates, Shannon Grant, Nicole Grunenberg, Glenda Gray, Peter B. Gilbert, Ashley Clayton, Laura Polakowski, April K. Randhawa, Sheetal Sawant, Mary Allen, Xue Han, Ying Huang, Janine Maenza, Kelly E. Seaton, Paul Spearman, Ann Duerr, Yunda Huang, Aaron Deal, Gavin J. Churchyard, Georgia D. Tomaras, Paul A. Goepfert
Publikováno v:
npj Vaccines, Vol 6, Iss 1, Pp 1-11 (2021)
NPJ Vaccines
NPJ Vaccines
We studied mucosal immune responses in six HIV-1 vaccine trials investigating different envelope (Env)-containing immunogens. Regimens were classified into four categories: DNA/vector, DNA/vector plus protein, protein alone, and vector alone. We meas
Autor:
Thomas R Hawn, Delia Scholes, Shuying S Li, Hongwei Wang, Yin Yang, Pacita L Roberts, Ann E Stapleton, Marta Janer, Alan Aderem, Walter E Stamm, Lue Ping Zhao, Thomas M Hooton
Publikováno v:
PLoS ONE, Vol 4, Iss 6, p e5990 (2009)
BACKGROUND:Although behavioral risk factors are strongly associated with urinary tract infection (UTI) risk, the role of genetics in acquiring this disease is poorly understood. METHODOLOGY/PRINCIPAL FINDINGS:To test the hypothesis that polymorphisms
Externí odkaz:
https://doaj.org/article/388c628acdbd4cce9322124ad02956cb
Autor:
James J. Kobie, M. Juliana McElrath, Song Ding, Ian Frank, Guido Ferrari, Magdalena E. Sobieszczyk, Faruk Sinangil, Cecilia Morgan, Nadine Rouphael, Aliza Norwood, Brittany Sanchez, Shelly Karuna, Stephen C. De Rosa, Shuying S. Li, Edith Swann, Hong Van Tieu, Ryan L. Jensen, Georgia D. Tomaras, Janine Maenza, Michael C. Keefer, David C. Montefiori, Giuseppe Pantaleo, Gregory J. Wilson
Publikováno v:
J Clin Invest
BACKGROUNDRV144 is the only preventive HIV vaccine regimen demonstrating efficacy in humans. Attempting to build upon RV144 immune responses, we conducted a phase 1, multicenter, randomized, double-blind trial to assess the safety and immunogenicity
Autor:
M. Juliana McElrath, Ian Frank, Shuying S. Li, Peter B. Gilbert, Nicole L. Yates, Allan C. deCamp, Mengshu Shao, Scott D. Neidich, Guido Ferrari, Shelly Karuna, Chul-Woo Pyo, Lawrence Corey, Magdalena E. Sobieszczyk, Xiaoying Shen, Georgia D. Tomaras, John R. Mascola, Raphael Gottardo, Frederick Feely, Hvtn Study Team, Lu Zhang, Youyi Fong, Barney S. Graham, Bryan Blette, Brian D. Williamson, Edith Swann, Daniel E. Geraghty, William Chad Young, Holly Janes, Kelly E. Seaton, Sheetal Sawant, Scott M. Hammer, Derrick Goodman
Publikováno v:
J Clin Invest
HVTN 505 is a preventative vaccine efficacy trial testing DNA followed by recombinant adenovirus serotype 5 (rAd5) in circumcised, Ad5-seronegative men and transgendered persons who have sex with men in the United States. Identified immune correlates